Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus

Journal of Diabetes Investigation

Volumn 2, Issue 2, 2011, Pages 148-153

  Uzui, Hiroyasu ^a   Nakano, Akira ^a   Mitsuke, Yasuhiko ^a   Geshi, Toru ^a   Sakata, Junji ^a   Sarazawa, Katsuhiko ^a   Morishita, Tetsuji ^a   Satou, Takehiko ^a   Ishida, Kentarou ^a   Lee, Jong Dae ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Arterial stiffness; Matrix metalloproteinases; Postprandial hyperglycemia

Indexed keywords

ACARBOSE; C REACTIVE PROTEIN; CD14 ANTIGEN; GELATINASE A; GELATINASE B; HEMOGLOBIN A1C; MATRIX METALLOPROTEINASE 14; PENTRAXIN 3;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIO ANKLE VASCULAR INDEX; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG TOLERABILITY; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT DURATION;

EID: 79961045895     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/j.2040-1124.2010.00079.x     Document Type: Article

References (29)

1. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987; 3: 463-524.
2. Ramlo-Halsted BA, Edelman SV. The natural history of Type 2 diabetes: practical points to consider in developing preven- tion and treatment strategies. Clin Diabetes 2000; 18: 80-85.
3. The DECODE study group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999; 354: 617-621.
4. Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999; 22: 920-924.
5. Azuma K, Kawamori R, Toyofuku Y, et al. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol 2006; 26: 2275-2280.
6. Chiasson JL, Josse RG, Gomis R, et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003; 290: 486-494.
7. Hanefeld M, Cagatay M, Petrowitsch T, et al. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 2004; 25: 10-16.
8. Nabata A, Kuroki M, Ueba H, et al. C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: implications for the destabilization of atherosclerotic plaque. Atherosclerosis 2008; 196: 129-135.
9. Death AK, Fisher EJ, McGrath KC, et al. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact onatherosclerosis in diabetes. Atherosclerosis 2003; 168: 263-269.
10. Nareika A, Sundararaj KP, Im YB, et al. High glucose and interferon gamma synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor STAT1 activity. Atherosclerosis 2009; 202: 363-371.
11. Wang YH, Chen SY, Wang TD, et al. The relationships among serum glucose, albumin concentrations and carotid atherosclerosis in men with spinal cord injury. Atherosclerosis 2009; 206: 528-534.
12. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107: 2864-2869.
13. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
14. Huang CL, Chen MF, Jeng JS, et al. Postchallenge hyperglycaemic spike associate with arterial stiffness. Int J Clin Pract 2007; 61: 397-402.
15. Cruickshank K, Riste L, Anderson SG, et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance. An integrated index of vascular function? Circulation 1999; 106: 2085-2090.
16. Gordin D, Rönnback M, Forsblom C, et al. Acute hyperglycaemia rapidly increases arterial stiffness in young patients with type 1 diabetes. Diabetologia 2007; 50: 1808-1814.
17. Hingorani AD, Shah T, Casas JP, et al. C-reactive protein and coronary heart disease: predictive test or therapeutic target? Clin Chem 2009; 55: 239-255.
18. Kato T, Inoue T, Node K. Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study. Cardiovasc Diabetol 2010; 9: 12-18.
19. Rosenbaum P, Peres RB, Zanella MT, et al. Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters. Braz J Med Biol Res 2002; 35: 877-884.
20. Hanefeld M, Chiasson JL, Koehler C, et al. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 2004; 35: 1073-1078.
21. Sun J, Xu Y, Dai Z, et al. Intermittent high glucose enhances proliferation of vascular smooth muscle cells by upregulating osteopontin. Mol Cell Endocrinol 2009; 313: 64-69.
22. Rajavashisth TB, Xu XP, Jovinge S, et al. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation 1999; 99: 3103-3109.
23. Sakamoto T, Seiki M. Cytoplasmic tail of MT1-MMP regulates macrophage motility independently from its protease activity. Genes Cells 2009; 14: 617-626.
24. Uzui H, Harpf A, Liu M, et al. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation 2002; 106: 3024-3030.
25. Uzui H, Nakano A, Mitsuke Y, et al. Membrane Type 1 Matrix Metalloproteinase Expression On Peripheral Blood Mononuclear Cells After Acute Myocardial Infarction. Circulation, 2007; 116: II_523.
26. Kubo T, Akasaka T. Recent advances in intracoronary imaging techniques: focus on optical coherence tomography. Expert Rev Med Devices 2008; 5: 691-697.
27. Uzui H, Lee JD, Shimizu H, et al. The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells. Atherosclerosis 2000; 149: 51-59.
28. Yue H, Lee JD, Shimizu H, et al. Effects of magnesium on the production of extracellular matrix metalloproteinases in cultured rat vascular smooth muscle cells. Atherosclerosis 2003; 166: 271-277.
29. Newby AC. Metalloproteinases and vulnerable atherosclerotic plaques. Trends Cardiovasc Med 2007; 17: 253-258.